Høvik, Lise Husby http://orcid.org/0000-0001-6380-029X
Gjeilo, Kari Hanne
Lydersen, Stian
Rickard, Claire M.
Røtvold, Benedikte
Damås, Jan Kristian
Solligård, Erik
Gustad, Lise Tuset
Article History
Received: 21 February 2019
Accepted: 30 August 2019
First Online: 5 September 2019
Change Date: 14 May 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via the original article.
Ethics approval and consent to participate
: The regional ethical committee considered this project to be a health quality research project among patients 18 year or older (2017/583/REK midt). Further, the study was approved by the Norwegian Centre for Research Data (NSD) (project number 55096). As the study was regarded a health quality research project and no directly identifiable patient information was collected, the NSD evaluated informed verbal consent as adequate. The patients received verbal and written information about the study and verbal informed consent was obtained from each patient before assessing the PIVC. The patient consent was registered in a separate screening log.PIVCs were not screened if the patient was unstable or in need of extra surveillance, had isolation precautions due to infection control, cognitive impairments (inability to provide informed consent) or when the patient declined consent. We were not allowed to record any patient identifying characteristics such as name, birthdate or hospital ID number (2017/583/REK midt, NSD project number 55096) and we were not allowed to collect any data of the patients that did not participate. All the data are thus anonymous and cannot be traced back to the patient. The ethical approval also mandated that rater #2 ensured appropriate actions related to the signs and symptoms found related to the PIVC.
: Not applicable.
: None declared.